Company Filing History:
1 out of 7 
1 out of 1 Years Active: 1984-1987
Title: The Innovative Contributions of Elena B Astapenok
Introduction
Elena B Astapenok is a notable inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compositions. With a total of 2 patents, her work has the potential to impact cancer treatment significantly.
Latest Patents
Astapenok's latest patents include a pharmaceutical composition and method for treating tumors susceptible to 2-carbamoylaziridine. This composition possesses antitumor activity against specific tumors and consists of a therapeutically effective quantity of a 1-H-2-aziridinecarbonic acid derivative. The formulation demonstrates high activity against tumors, a wide spectrum of antitumor effects, and low toxicity, with an LD50 within the range of 3,000 to 3,500 mg/kg. Additionally, she has developed a novel compound, 3-(2,2,2-trimethylhydrazinium)propionate, which has promising applications in the pharmaceutical industry.
Career Highlights
Throughout her career, Astapenok has worked at prestigious institutions such as the Institute of Organic Synthesis of the Academy of Sciences of the Latvian SSR and the Institute of Organic Synthesis of the Academy of Sciences of the USSR. Her research has focused on innovative solutions in organic chemistry and pharmaceuticals.
Collaborations
Astapenok has collaborated with notable colleagues, including Ivars Y Kalvinsh and Anatoly Eremeev. These partnerships have contributed to her research and the advancement of her inventions.
Conclusion
Elena B Astapenok's contributions to pharmaceutical innovation highlight her role as a significant inventor in the field. Her patents and research have the potential to advance cancer treatment and improve patient outcomes.